Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Axcella Health Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 2 | 1 | 0 | −1 |
| Shares | 140 | 80 | 0 | −60 (−100.0%) |
| Value | $0 | $0 | $0 | $0 |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Axcella Health Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (1)
Institutions that held Axcella Health Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Global Financial Private Client, LLC | 60 | $0 |
Not filed for Q2 2025 yet (1)
Institutions that held Axcella Health Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 80 | $0 |